It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Thank you.
Some features of ATS will be disabled while you continue to use an ad-blocker.
originally posted by: tamusan
a reply to: SleeperHasAwakened
It's not just a U.S. problem. Governments around the world were quick to start pushing the vaccines on their people. If there is something afoot, they are all likely in on it together.
Other countries are tracking all of the breakthrough cases and that is the way to see that the vaccines aren't going to stop the pandemic. Vaccinated can still catch delta and most likely spread it even if they don't get sick. That means there will be chances for mutations even if every last one of us were vaccinated. That's why the masks came back. The CDC says they are not tracking less severe cases, but the truth is more likely that they are and just not reporting them accurately. Otherwise more folks would notice the vaccines weren't necessarily going to stop the pandemic and that would get in the way of getting more people to comply.
originally posted by: tamusan
a reply to: SleeperHasAwakened
It's not just a U.S. problem. Governments around the world were quick to start pushing the vaccines on their people. If there is something afoot, they are all likely in on it together.
originally posted by: tamusan
a reply to: 1947boomer
You don't know what you are talking about for this virus and vaccines. And where was I talking about pandemic growth? I was talking about mutations.
The vaccines are keeping the vast majority of people from getting sick enough for the hospital. That's really all. It's not stopping all of us from catching it. Every time a vaccinated person catches it there is a chance for it to mutate to better breakthrough.
Do you really think they are bringing masks back to save the unvaccinated?
originally posted by: tamusan
a reply to: 1947boomer
Do you really think they are bringing masks back to save the unvaccinated?
RICHARD HARRIS, BYLINE: You may have heard that bacteria can develop resistance to antibiotics and, in a worst-case scenario, render the drugs useless. Something similar can also happen with vaccines, though, with less serious consequences. This worry has arisen mostly in the debate over whether to delay a second vaccine shot so more people can get the first shot quickly. Paul Bieniasz, a Howard Hughes investigator at the Rockefeller University, says that gap would leave people with only partial immunity for longer than necessary.
PAUL BIENIASZ: They might serve as sort of a breeding ground for the virus to acquire new mutations.
HARRIS: That's because the virus is always mutating. And if one happens to produce a mutation that makes it less vulnerable to the vaccine, that virus could simply multiply in a vaccinated individual. But even if that happens, that's only one step in the process.
BIENIASZ: What's really unclear and really quite important for the virus to evolve is whether those people let - having been vaccinated and infected, whether they have sufficient levels of virus replication to pass the virus on to other people.
There is a theoretical expectation that some types of vaccines could prompt the evolution of more virulent (“hotter”) pathogens. This idea follows from the notion that natural selection removes pathogen strains that are so “hot” that they kill their hosts and, therefore, themselves. Vaccines that let the hosts survive but do not prevent the spread of the pathogen relax this selection, allowing the evolution of hotter pathogens to occur. This type of vaccine is often called a leaky vaccine. When vaccines prevent transmission, as is the case for nearly all vaccines used in humans, this type of evolution towards increased virulence is blocked. But when vaccines leak, allowing at least some pathogen transmission, they could create the ecological conditions that would allow hot strains to emerge and persist. This theory proved highly controversial when it was first proposed over a decade ago, but here we report experiments with Marek’s disease virus in poultry that show that modern commercial leaky vaccines can have precisely this effect: they allow the onward transmission of strains otherwise too lethal to persist. Thus, the use of leaky vaccines can facilitate the evolution of pathogen strains that put unvaccinated hosts at greater risk of severe disease. The future challenge is to identify whether there are other types of vaccines used in animals and humans that might also generate these evolutionary risks.